Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 1
1(25.0%)
4Total
N/A(3)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT04518670Completed

Success in Comaneci-assist Coils Embolization Surveillance Study (SUCCESS)

Role: lead

NCT05152524Not ApplicableActive Not Recruiting

Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever

Role: lead

NCT05531461Recruiting

Cognition and Imaging With Tigertriever

Role: lead

NCT05029414Not ApplicableActive Not Recruiting

EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke

Role: collaborator

NCT03474549Not ApplicableCompleted

Treatment With Intent to Generate Endovascular Reperfusion

Role: lead

NCT03871309Terminated

Tigertriever Distal Vessels Registry

Role: lead

NCT01404403Phase 1Completed

Safety Study of the Rapid System for Acute Ischemic Stroke

Role: lead

All 7 trials loaded